Where Global Innovation
and Capital Meet

Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Prevail completes $75m series A process

Mar 12, 2018 • Robert Lavine

Neurodegenerative disease startup Prevail Therapeutics has raised series A funding from backers including Alexandria Venture Investments.

US-based gene therapy developer Prevail Therapeutics has secured $75m in a series A round featuring Alexandria Venture Investments, the venture capital arm of life sciences real estate trust Alexandria Real Estate Equities.

OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners, Boxer Capital and Adage Capital Management also took part in the round.

Prevail is working on gene therapies to treat genetically-defined neurodegenerative diseases such as Parkinson’s disease. Its lead product candidate, known as PR001, is concentrated…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.

SURVEY

Benchmark your unit against industry norms. Participants will receive a free copy of the survey results

CVC DIRECTORY

Which corporates have venture capital units and what do they focus on?

Events

Webinar: Strategic LP/GP relationships - Creating the win-win

Oct 9, 2024
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

Oct 17 -
Oct 21, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Oct 22 -
Oct 23, 2024
Palo Alto, CA (USA)

Find out more All events

Events

GCV Executive Leadership Forum 2024

Oct 24, 2024
Menlo Park, CA (USA)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

Events

GCV Connect: Germany 2024

Oct 29, 2024
Frankfurt (Germany)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Oct 30 -
Oct 31, 2024
Frankfurt (Germany)

Find out more All events

Events

GCV Asia Congress & International Delegation 2024

Nov 11 -
Nov 14, 2024
Tokyo (Japan)

Find out more All events

Events

GCV Connect: Korea 2024

Dec 10 -
Dec 12, 2024
Seoul (South Korea)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.